MASS Stock Overview
908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
908 Devices Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$5.70 |
| 52 Week High | US$12.51 |
| 52 Week Low | US$4.85 |
| Beta | 0.93 |
| 1 Month Change | -24.50% |
| 3 Month Change | -19.49% |
| 1 Year Change | -1.30% |
| 3 Year Change | -89.02% |
| 5 Year Change | n/a |
| Change since IPO | -88.37% |
Recent News & Updates
Recent updates
We Think 908 Devices (NASDAQ:MASS) Can Afford To Drive Business Growth
Mar 30
Investors Appear Satisfied With 908 Devices Inc.'s (NASDAQ:MASS) Prospects
Dec 18908 Devices Q2 2022 Earnings Preview
Aug 08908 Devices Aims For Broadened Footprint
Feb 02908 Devices and Bio-Techne collaborate for extended workflow solution
May 04Shareholder Returns
| MASS | US Electronic | US Market | |
|---|---|---|---|
| 7D | 2.5% | 1.6% | -0.7% |
| 1Y | -1.3% | 22.8% | 22.3% |
Return vs Industry: MASS underperformed the US Electronic industry which returned 21.9% over the past year.
Return vs Market: MASS underperformed the US Market which returned 22.8% over the past year.
Price Volatility
| MASS volatility | |
|---|---|
| MASS Average Weekly Movement | 8.3% |
| Electronic Industry Average Movement | 6.9% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in US Market | 16.7% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: MASS's share price has been volatile over the past 3 months.
Volatility Over Time: MASS's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2012 | 230 | Kevin Knopp | 908devices.com |
908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. The company’s products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and Maverick, an optical in-line analyzer that offers real-time monitoring and control of multiple bioprocess parameters, including glucose, lactate, and total biomass in mammalian cell cultures, as well as provides process fingerprint data to support large-scale efforts in predictive bioprocess modeling. Its products also comprise Maven and Trace C2, an online device for bioprocess monitoring and control; and ZipChip solution, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis.
908 Devices Inc. Fundamentals Summary
| MASS fundamental statistics | |
|---|---|
| Market cap | US$188.00m |
| Earnings (TTM) | -US$36.40m |
| Revenue (TTM) | US$50.23m |
3.7x
P/S Ratio-5.2x
P/E RatioIs MASS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MASS income statement (TTM) | |
|---|---|
| Revenue | US$50.23m |
| Cost of Revenue | US$24.91m |
| Gross Profit | US$25.32m |
| Other Expenses | US$61.72m |
| Earnings | -US$36.40m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -1.10 |
| Gross Margin | 50.41% |
| Net Profit Margin | -72.47% |
| Debt/Equity Ratio | 0% |
How did MASS perform over the long term?
See historical performance and comparison